article thumbnail

Beneficiary inducements…don’t cross that line

YouCompli

However, some key words and phrases should at least pique the interest of a conscientious compliance officer. “Co-pay The doctor also agreed to be excluded from participation in any federal healthcare program for three years followed by an OIG Integrity Agreement for another three years. Read more about? our model procedures.

article thumbnail

Enhancing Workflow Automation for Healthcare Professionals

HIT Consultant

As a result, providers can avoid human error, and employees can spend less time on mundane tasks — all while maintaining HIPAA compliance. If this individual is unavailable, data entry falls once again onto the shoulders of doctors or nurses. Prior to founding Paubox , Hoala started Hawaii’s first SaaS company (Pau Spam) in 2002.

HIPAA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New HIPAA Regulations in 2022-2023

HIPAA Journal

If details of treatment for SUD are withheld from doctors, there is a risk that a patient may be prescribed opioids when they are in recovery. The compliance date for the CMS rule was July 1, 2021. It was starting to look like OCR was easing up on its enforcement of compliance with the HIPAA Rules.

HIPAA 128
article thumbnail

Another Update on Medical Abortion Litigation

Drug & Device Law

If the laughably low standing standards permitted in Hippo III are, in fact, the law, then our side’s ability to assert preemption, compliance, and other defenses that presuppose the validity of FDA decisions will be threatened. 435, 436 (2002). Linda Greenhouse, “Thinking About the Supreme Court After Bush v. Gore ,” 35 Ind.

FDA 52
article thumbnail

Another Update on Medical Abortion Litigation

Drug & Device Law

If the laughably low standing standards permitted in Hippo III are, in fact, the law, then our side’s ability to assert preemption, compliance, and other defenses that presuppose the validity of FDA decisions will be threatened. 435, 436 (2002). Linda Greenhouse, “Thinking About the Supreme Court After Bush v. Gore ,” 35 Ind.

FDA 59